1. James, Michael A, Lu, Yan, Liu, Yan, Vikis, Haris G, You, Ming. 2009. RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway. In Cancer research, 69, 2108-16. doi:10.1158/0008-5472.CAN-08-3495. https://pubmed.ncbi.nlm.nih.gov/19244110/
2. You, Ming, Wang, Daolong, Liu, Pengyuan, Amos, Christopher I, Anderson, Marshall W. 2009. Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. In Clinical cancer research : an official journal of the American Association for Cancer Research, 15, 2666-74. doi:10.1158/1078-0432.CCR-08-2335. https://pubmed.ncbi.nlm.nih.gov/19351763/
3. Zhang, Huiping, Wang, Fan, Kranzler, Henry R, Anton, Raymond F, Gelernter, Joel. 2012. Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses. In Behavioral and brain functions : BBF, 8, 23. doi:10.1186/1744-9081-8-23. https://pubmed.ncbi.nlm.nih.gov/22591552/
4. Bottoni, Laura, Minetti, Alberto, Realini, Giulia, Chiariello, Mario, Galvagni, Federico. 2024. NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells. In Oncogene, 43, 1701-1713. doi:10.1038/s41388-024-03025-0. https://pubmed.ncbi.nlm.nih.gov/38600165/
5. Zhang, L-S, Ma, H-G, Sun, F-H, Zhao, W-C, Li, G. . MiR-203 inhibits the malignant behavior of prostate cancer cells by targeting RGS17. In European review for medical and pharmacological sciences, 23, 5667-5674. doi:10.26355/eurrev_201907_18303. https://pubmed.ncbi.nlm.nih.gov/31298318/
6. Sokolov, Eugene, Iannitti, David A, Schrum, Laura W, McKillop, Iain H. 2011. Altered expression and function of regulator of G-protein signaling-17 (RGS17) in hepatocellular carcinoma. In Cellular signalling, 23, 1603-10. doi:10.1016/j.cellsig.2011.05.012. https://pubmed.ncbi.nlm.nih.gov/21620966/